This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sosnovik, D. E. Articles by Weissleder, R. Search for Related Content PubMed PubMed Citation Articles by Sosnovik, D. E. Articles by Weissleder, R. Related Collections Cardiovascular imaging agents/Techniques Animal models of human disease Pathophysiology Imaging CT and MRI Acute myocardial infarction

(Circulation. 2007;115:2076-2086.)
© 2007 American Heart Association, Inc.

New Drugs and Technologies

Molecular Magnetic Resonance Imaging in Cardiovascular Medicine

David E. Sosnovik, MD; Matthias Nahrendorf, MD; Ralph Weissleder, MD, PhD

From the Center for Molecular Imaging Research (D.E.S., M.N., R.W.) and the Department of Cardiology (D.E.S.), Massachusetts General Hospital, Harvard Medical School, Boston, Mass.

Correspondence to David Sosnovik, MD, FACC, Center for Molecular Imaging Research, Massachusetts General Hospital, 149 13th St, Charlestown, MA 02129. E-mail sosnovik@nmr.mgh.harvard.edu

Key Words: atherosclerosis • cardiovascular diseases • magnetic resonance imaging • myocardium • nanotechnology

An extract of the first 250 words of the full text is provided, because this article has no abstract.

	Introduction

 
The ability of magnetic resonance imaging (MRI) to evaluate cardiovascular pathophysiology at several levels is one of the strengths of the technique. As shown in Figure 1, cardiac phenotype can be assessed at the whole-organ level by cine MRI, at the regional level with strain, perfusion, and viability imaging, and at the metabolic level with spectroscopic techniques.^1,2 However, MRI of biological processes at the cellular and subcellular level (molecular MRI) has been studied most extensively in other disease states such as cancer.^3,4 Molecular MRI techniques are, however, being increasingly developed for cardiovascular applications and, if fully developed, have the potential to make a significant impact on the practice of cardiovascular medicine.

View larger version (60K):   Figure 1. Comprehensive analysis of cardiac phenotype by MRI. A, cine MRI of a mouse heart; B, area of myocardial infarction delineated by delayed enhancement MRI in a mouse heart; C, corresponding triphenyltetrazolium (TTC) image. D, map of myocardial perfusion (ml/g per min) in a mouse heart obtained with a spin labeling technique;1 E, strain rate imaging at the midventricular level in a wild-type mouse;1 F, a phosphocreatine metabolite map in an isolated perfused rat heart fused with the corresponding coronary angiogram.2 Comprehensive imaging of the human heart can be performed with identical techniques. Molecular MRI thus offers the potential for complete anatomic, functional, metabolic, and molecular imaging with a single modality from bench to bedside.

The advantages of an MRI-based approach to molecular imaging reflect the general attributes of the technique. MRI is noninvasive, tomographic, nonionizing, and . . . [Full Text of this Article]

This article has been cited by other articles:

				D. E. Sosnovik, M. Nahrendorf, P. Panizzi, T. Matsui, E. Aikawa, G. Dai, L. Li, F. Reynolds, G. W. Dorn II, R. Weissleder, et al. Molecular MRI Detects Low Levels of Cardiomyocyte Apoptosis in a Transgenic Model of Chronic Heart Failure Circ Cardiovasc Imaging, November 1, 2009; 2(6): 468 - 475. [Abstract] [Full Text] [PDF]

				D. E. Sosnovik Will Molecular MR Imaging Play a Role in Identification and Treatment of Patients with Vulnerable Atherosclerotic Plaques? Radiology, May 1, 2009; 251(2): 309 - 310. [Full Text] [PDF]

				D. E. Sosnovik, R. Wang, G. Dai, T. Wang, E. Aikawa, M. Novikov, A. Rosenzweig, R. J. Gilbert, and V. J. Wedeen Diffusion Spectrum MRI Tractography Reveals the Presence of a Complex Network of Residual Myofibers in Infarcted Myocardium Circ Cardiovasc Imaging, May 1, 2009; 2(3): 206 - 212. [Abstract] [Full Text] [PDF]

				E. J CHURCH Imaging Diabetes Radiol. Technol., March 1, 2009; 80(4): 340 - 360. [Abstract] [Full Text] [PDF]

				M. Nahrendorf, D. E. Sosnovik, B. A. French, F. K. Swirski, F. Bengel, M. M. Sadeghi, J. R. Lindner, J. C. Wu, D. L. Kraitchman, Z. A. Fayad, et al. Multimodality Cardiovascular Molecular Imaging, Part II Circ Cardiovasc Imaging, January 1, 2009; 2(1): 56 - 70. [Full Text] [PDF]

				C. von zur Muhlen, D. von Elverfeldt, J.A. Moeller, R.P. Choudhury, D. Paul, C.E. Hagemeyer, M. Olschewski, A. Becker, I. Neudorfer, N. Bassler, et al. Magnetic Resonance Imaging Contrast Agent Targeted Toward Activated Platelets Allows In Vivo Detection of Thrombosis and Monitoring of Thrombolysis Circulation, July 15, 2008; 118(3): 258 - 267. [Abstract] [Full Text] [PDF]

				M. Nahrendorf, H. Zhang, S. Hembrador, P. Panizzi, D. E. Sosnovik, E. Aikawa, P. Libby, F. K. Swirski, and R. Weissleder Nanoparticle PET-CT Imaging of Macrophages in Inflammatory Atherosclerosis Circulation, January 22, 2008; 117(3): 379 - 387. [Abstract] [Full Text] [PDF]